INFLUENCE OF RANGE OF RENAL-FUNCTION AND LIVER-DISEASE ON PREDICTABILITY OF CREATININE CLEARANCE

被引：134
作者：
HULL, JH
HAK, LJ
KOCH, GG
WARGIN, WA
CHI, SL
MATTOCKS, AM
机构：
[1] UNIV N CAROLINA, SCH PHARM, CHAPEL HILL, NC 27514 USA
[2] UNIV N CAROLINA, SCH MED, CHAPEL HILL, NC 27514 USA
[3] UNIV N CAROLINA, SCH PUBL HLTH, CHAPEL HILL, NC 27514 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1981年 / 29卷 / 04期
关键词：
D O I：
10.1038/clpt.1981.72
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：516 / 521
页数：6
相关论文
共 19 条
[1]   USE OF SERUM CREATININE CONCENTRATIONS TO DETERMINE RENAL-FUNCTION [J].
BJORNSSON, TD .
CLINICAL PHARMACOKINETICS, 1979, 4 (03) :200-222
[2]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[3]   GENTAMICIN THERAPY [J].
DEVINE, BJ .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11) :650-655
[4]  
GAULT MH, 1975, LANCET, V2, P612
[5]  
JELLIFFE R W, 1972, Mathematical Biosciences, V14, P17, DOI 10.1016/0025-5564(72)90003-X
[6]   CREATININE CLEARANCE - BEDSIDE ESTIMATE [J].
JELLIFFE, RW .
ANNALS OF INTERNAL MEDICINE, 1973, 79 (04) :604-605
[7]  
JELLIFFE RW, 1971, LANCET, V1, P975
[8]  
JELLIFFE RW, 1971, LANCET, V2, P710
[9]  
JONES WN, 1978, AM J HOSP PHARM, V35, P1183
[10]  
KAMPMANN J, 1974, ACTA MED SCAND, V196, P517
12